Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.
01 3AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
02 1BEXAROTENE
03 1CELLCEPT
04 2CETIRIZINE HYDROCHLORIDE ALLERGY
05 1CYCLOSPORINE
06 1DICLOFENAC POTASSIUM
07 1ETHOSUXIMIDE
08 1FLUOXETINE HYDROCHLORIDE
09 1IBUPROFEN
10 1ICOSAPENT ETHYL
11 2MYCOPHENOLATE MOFETIL
12 1NAPROXEN SODIUM
13 3NIMODIPINE
14 1OMEGA-3-ACID ETHYL ESTERS
15 1OXSORALEN-ULTRA
16 1PROGESTERONE
17 1TARGRETIN
18 1TRIAMTERENE AND HYDROCHLOROTHIAZIDE
19 1ZIPSOR
01 119600
02 121055
03 121920
04 122202
05 140686
06 150722
07 165017
08 174701
09 176001
10 176740
11 177890
12 178381
13 190103
14 190364
15 190762
16 1201832
17 1202121
18 1203174
19 1203599
20 1205291
21 1207235
22 1209457
23 1210078
24 1210181
25 1211355
01 23No
02 2Yes
Drug : DICLOFENAC POTASSIUM
Dosage Form : CAPSULE; ORAL
Application Number : 210078
Country : US
Patented : No
Drug : CETIRIZINE HYDROCHLORIDE ALLERGY
Dosage Form : CAPSULE; ORAL
Application Number : 205291
Country : US
Patented : No
AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE
Drug : AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
Dosage Form : CAPSULE; ORAL
Application Number : 78381
Country : US
Patented : No
Drug : BEXAROTENE
Dosage Form : CAPSULE; ORAL
Application Number : 203174
Country : US
Patented : No
Drug : NIMODIPINE
Dosage Form : CAPSULE; ORAL
Application Number : 76740
Country : US
Patented : No
Drug : NAPROXEN SODIUM
Dosage Form : CAPSULE; ORAL
Application Number : 21920
Country : US
Patented : Yes
Drug : CELLCEPT
Dosage Form : CAPSULE; ORAL
Application Number : 50722
Country : US
Patented : No
Drug : NIMODIPINE
Dosage Form : CAPSULE; ORAL
Application Number : 201832
Country : US
Patented : No
HYDROCHLOROTHIAZIDE; TRIAMTERENE
Drug : TRIAMTERENE AND HYDROCHLOROTHIAZIDE
Dosage Form : CAPSULE; ORAL
Application Number : 74701
Country : US
Patented : No
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
LOOKING FOR A SUPPLIER?